The 20 Best Pancreaticoduodenectomy Doctors near Ann Arbor, MI

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as a Distinguished provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.

Raymond A. Jean, MD MHS is a faculty member in the Division of Acute Care Surgery. Dr. Jean graduated with an A.B. in Engineering Sciences from Harvard University. He went on to receive his medical degree from the Washington University in St. Louis School of Medicine, where in addition to an M.D., he received a M.A. in outcomes research. He then completed his internship and residency in General Surgery at Yale-New Haven Hospital in Connecticut. During that time, he also obtained a M.H.S. degree from the Yale School of Medicine. He then completed a fellowship in Trauma and Surgical Critical Care at the University of Washington’s Harborview Medical Center in Seattle, Washington before joining the Division of Acute Care Surgery at the University of Michigan.Clinical Specialization:Dr. Jean specializes in the surgical treatment and management of patients who suffer injuries from trauma, or emergent general surgery conditions. Furthermore, he specializes in surgical critical care and management of patients in the Trauma/Burn Intensive Care Unit. Dr. Jean is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Retroperitoneal Inflammation, Ogilvie Syndrome, Acute Respiratory Distress Syndrome (ARDS), Small Bowel Resection, and Appendectomy.

Max Wayne is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Wayne is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Pulmonary Alveolar Proteinosis, Lymphofollicular Hyperplasia, Endoscopy, and Pancreaticoduodenectomy.

Hero Hussain is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Hussain is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Fibrolamellar Carcinoma, Ureterocele, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Prostatectomy. Dr. Hussain is board certified in Diagnostic Radiology.

Dr. Hari Nathan is a board-certified complex general surgical oncologist and Associate Professor of Surgery with Tenure. Dr. Nathan completed both his undergraduate and medical education with honors at The Johns Hopkins University. He also completed advanced training in health services research and was awarded a PhD from The Johns Hopkins Bloomberg School of Public Health. Dr. Nathan completed his clinical residency training in general surgery at The Johns Hopkins Hospital. He subsequently completed a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center, where he also served as the Chief Administrative Fellow in Surgery. He joined the faculty of the University of Michigan in 2014. Clinical Specialization: Dr. Nathan's clinical focus includes the multi-disciplinary treatment of tumors of the pancreas, liver, bile duct, and stomach. He has particular interests in the treatment of liver metastases from colorectal cancer and directs Michigan Medicine’s Hepatic Artery Infusion Pump (HAIP) Program. He also serves as the Surgical Director of the Multidisciplinary Pancreatic Cancer Clinic, coordinating the efforts of a multidisciplinary team at the busiest pancreatic cancer program in Michigan. Dr. Nathan is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Nathan is board certified in Surgery and Complex General Surgical Oncology.

Evan Glazer, MD, PhD, FACS, is the Clinical Director of the Pancreatic Cancer Program at Michigan Medicine and the Associate Director of Clinical Research in the Rogel and Blondy Center for Pancreatic Cancer. Dr. Glazer earned his medical degree and a master's degree in public health at the George Washington University in Washington, DC. Subsequently, he completed residency in general surgery and completed a PhD in Cancer Biology at the University of Arizona, in Tucson, AZ. Dr. Glazer completed an NIH funded T32 training fellowship at the M.D. Anderson Cancer Center in Houston, TX. He completed a fellowship in complex general surgical oncology at the H. Lee Moffitt Cancer Center in Tampa, FL. Dr. Glazer is board certified in complex general surgical oncology and general surgery. His clinical and research focuses are on pancreatic and liver malignancies.After completing fellowship in Tampa, Dr. Glazer joined the University of Tennessee Health Science Center in Memphis, TN, and rose in rank to Associate Professor. He served as program director of the complex general surgical oncology fellowship there as well as associate program director for research in the general surgery residency program. Dr. Glazer is a member of the American College of Surgeons, American Association for Cancer Research, Society of Surgical Oncology, Association of Academic Surgery, and American Society of Clinical Oncology. With a national reputation, he has served on the Hepatobiliary Panel and Pancreatic Adenocarcinoma Panel for the National Comprehensive Cancer Network. He has served numerous roles for the Society of Surgical Oncology. Dr. Glazer is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Glazer is board certified in Surgery and Complex General Surgical Oncology.

Dr. Fukuhara earned his medical degree from Keio University School of Medicine in Tokyo, Japan (2006), where he also received training in surgery (2009) and cardiovascular surgery (2010) with intense endovascular experience. After moving to the United States, he completed his general surgery residency at Beth Israel Medical Center, New York, NY (2014), cardiothoracic surgery residency at Columbia University Medical Center, New York, NY (2016), aortic surgery fellowship at University of Pennsylvania, Philadelphia, PA (2017), and aortic and endovascular fellowship at the Cleveland Clinic, Cleveland, OH (2018). He is board certified by the American Board of Surgery, the American Board of Thoracic Surgery and the Japan Surgical Society. Dr. Fukuhara is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Aortic Dissection, Aortic Valve Stenosis, Thoracic Aortic Aneurysm, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Fukuhara is board certified in Surgery and Thoracic & Cardiac Surgery.

Dr. Timothy L. Frankel is a faculty member within the Section of General Surgery at the University of Michigan. He graduated Magna Cum Laude from Connecticut College in 2000 with a B.A. in Physics and was elected into Phi Beta Kappa. He earned his medical degree from George Washington University in 2004 and was inducted into the Alpha Omega Alpha Honor Medical Society. He completed a residency in General Surgery at the University of Michigan in 2011 during which time he spent two years at the National Cancer Institute studying tumor immunology and genetic engineering. He developed techniques to genetically modify peripheral blood lymphocytes allowing them to more effectively target tumors for destruction. His work resulted in multiple publications and awards including the James Crudup Surgical Research Award. After completion of residency, he completed a two-year surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York. Clinical Specialization:His clinical interests are in the treatment of gastrointestinal malignancies including cancers of the liver, pancreas and stomach. He has published multiple clinical papers on techniques in liver resection for colorectal metastases. Dr. Frankel is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Frankel is board certified in Surgery and Complex General Surgical Oncology.

Dr. Bednar is a faculty member in the Department of Surgery at the University of Michigan.His undergraduate training was done at Princeton University, where he graduated with a Bachelor of Arts degree in molecular biology in 2000. After that he transitioned to the Lewis Katz School of Medicine of Temple University in Philadelphia. Dr. Bednar spent seven years in the combined MD/PhD program where he earned an MD and PhD in Microbiology and Immunology in the laboratory of Dr. Thomas Rogers. His dissertation thesis focused on how human monocytes respond to the complex external environment present during an infection or inflammatory state. After the completion of his medical training he was accepted to the General Surgery Residency program at the University of Michigan. During his time in Ann Arbor, he also spent two years in a postdoctoral research fellowship in the laboratories of Dr. Diane Simeone and Dr. Marina Pasca di Magliano. During Dr. Bednar's research time, he studied the basic biology of pancreatic cancer, which led to his evolving interest in cancer patient care. He finished his clinical training in the Complex General Surgical Oncology Fellowship program at the University of Pittsburgh and was recruited back to the University of Michigan to become a part of the pancreatic cancer research group that has developed here in the past decade. Dr. Bednar is a board-certified general surgeon and currently undergoing board certification for additional specialization of Complex General Surgical Oncology. He is also BLS/ACLS certified.Dr. Bednar's clinical and research effort up to now has been recognized through several awards. He received the Dr. Herman Brown Award for Excellence in the Study of the Art and Science of Surgery from the Department of Surgery, Lewis Katz School of Medicine, Temple University as a recognition for his care of the surgical patients and his research work while he was a medical student. Dr. Bednar's work on pancreatic cancer was recognized and supported by an American College of Surgeons Research Fellowship. He also received the Robert V. Danto Cancer Research Award from the Michigan chapter of the American College of Surgeons for his postdoctoral research work. His work was chosen to be presented at the Owen Wangensteen Surgical Forum during the annual American College of Surgeons meeting in 2013 and received the Best Oral Presentation award at the 24th Annual Moses Gunn Research Conference of the Department of Surgery at the University of Michigan in 2012.Clinical Specialization:Dr. Bednar is a practicing general and oncologic surgeon. His practice encompasses the full gamut of general surgery and complex abdominal and soft tissue surgical oncology. During his fellowship training, he also received specific instruction on the DaVinci robotic surgery platform and hope to continue to support the already-established efforts in this arena. Dr. Bednar is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bednar is board certified in Surgery and Complex General Surgical Oncology.

Dr. Susan Pitt, MD, MPHS is an Associate Professor of Surgery and Director of the Endocrine Surgery Health Services Research Program in the Department of Surgery at Michigan Medicine. Dr. Pitt graduated Magna Cum Laude with a B.A. in psychology from Boston College in Chestnut Hill, MA. She received her medical degree from the Medical College of Wisconsin and a Masters degree in Population Health Science from Washington University in St. Louis which was supported by a scholarship from the BJC Healthcare Institute for Public Health. Dr. Pitt completed her general surgery residency at Washington University in St. Louis with Alpha Omega Alpha honors and was both the resident representative and administrative chief resident. During a two-year post-doctoral research fellowship at the University of Wisconsin, she was awarded a Ruth L. Kirschstein T32 training grant from the National Institutes of Health and the American College of Surgeons Resident Research Scholarship to study signaling pathways in neuroendocrine cancers. Following residency, Dr. Pitt completed an Endocrine Surgery Fellowship at Brigham & Women’s Hospital in Boston, MA before serving as an Assistant Professor of Surgery for six years at the University of Wisconsin in Madison, WI. Dr. Pitt joined the faculty of the University of Michigan in 2021.Dr. Pitt has received multiple awards for her clinical, research, and teaching efforts including the American Medical Women’s Association Exceptional Mentor Award in 2018 and an award from the University of Wisconsin-Madison Women in Science & Engineering Leadership Institute. She is a Fellow of the American College of Surgeons and active member of multiple organizations including the Association of Academic Surgery, Society of University Surgeons, American Association of Endocrine Surgeons, American Thyroid Association, Surgical Outcomes Club, Association of Women Surgeons, and Society for Medical Decision Making.Clinical Specialization: Dr. Pitt’s clinical interests include surgical diseases of the endocrine system including the thyroid, parathyroid, and adrenal glands. She has a particular interest and experience in the diagnosis and treatment of papillary thyroid cancer, functional adrenal tumors, and complex parathyroid disease. Dr. Pitt works closely with her endocrine oncology partners to provide excellent patient care and outcomes. Dr. Pitt is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Pitt is board certified in Surgery.

Dr. Sheetz is an assistant professor of surgery and a faculty member in the Section of Transplant Surgery. He received his medical degree from the University of Michigan where he also completed his general surgery residency. He went on to complete his transplant surgery fellowship at the University of California San Francisco (UCSF). He is board certified by the American Board of Surgery and is a member of the American College of Surgeons and American Society of Transplant Surgeons.Clinical Specialization: Dr. Sheetz’s clinical interests include liver, kidney, and pancreas transplant. He also performs laparoscopic donor nephrectomy for living donor kidney transplants. He has a special interest in normothermic machine perfusion in liver transplant. Dr. Sheetz is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Liver Failure, End-Stage Renal Disease (ESRD), Umbilical Hernia, Gallbladder Removal, and Liver Transplant. Dr. Sheetz is board certified in Surgery.

David Odell is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Odell is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy.

Christopher Sonnenday, M.D., M.H.S., is the Darrell A. Campbell, Jr, M.D., Collegiate Professor of Transplant Surgery at the University of Michigan and Transplant Center Director for University of Michigan Health. He serves as Executive Vice Chair of the Department of Surgery, Surgical Director of Living Donor Liver Transplantation, and Surgical Director of the Multidisciplinary Liver Tumor Program for Michigan Medicine. He is a Professor in the Department of Surgery, Section of Transplantation, and Professor of Health Management and Policy at the School of Public Health. Dr. Sonnenday received his medical degree from Vanderbilt University in 1997, and completed his General Surgery residency at the Johns Hopkins University in 2005. While a research fellow in transplantation from 2000 to 2003, he completed a Masters of Health Sciences in Clinical Investigation at the Bloomberg School of Public Health. After completion of his residency, Dr. Sonnenday continued at Johns Hopkins as a Fellow in Surgical Oncology and Instructor of Surgery until 2006, and he completed a fellowship in abdominal transplant surgery at the University of Michigan in 2008. His primary academic and research interests include the study of frailty in liver transplant candidates, machine perfusion in liver transplantation, the overlap of transplant and oncology, quality collaboratives in transplantation, and leadership development in academic surgery.Clinical Specialization: Dr. Sonnenday's clinical interests focus on liver transplantation, hepatobiliary and pancreatic surgery, and general surgery procedures in patients with advanced liver disease. He sees patients in the Multidisciplinary Liver Tumor Clinic at the University of Michigan Rogel Cancer Center and the Transplant Clinic at the Taubman Center. Dr. Sonnenday is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bile Duct Cysts, Liver Failure, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy. Dr. Sonnenday is board certified in Surgery.

Justin B. Dimick, M.D., M.P.H. is the Frederick A. Coller Distinguished Professor of Surgery and Chair of the Department of Surgery at the University of Michigan. Dr. Dimick is a graduate of Cornell University and Johns Hopkins Medical School. He completed his surgical training at the University of Michigan and a health services research fellowship at the Dartmouth Institute for Health Policy & Clinical Practice. Dr. Dimick has served in several national leadership positions, including President of the Association for Academic Surgery (AAS), Chair of the Health Services Organization and Delivery (HSOD) Study Section at the NIH, Associate Editor at Annals of Surgery, and the Surgical Innovation Editor at JAMA Surgery. He has served as an advisor on quality and health policy for several organizations, including the BlueCross BlueShield Association (BCBSA), the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP), US News and World Reports Best Hospital Rankings, and the Medicare Payment Advisory Commission (MedPAC).Clinical Specialization:Dr. Dimick's clinical practice is primarily devoted to advanced laparoscopy, including treatment of morbid obesity, gastroesophageal reflux (GERD), paraesophageal hernias, abdominal wall hernias, and other benign and neoplastic diseases of the stomach, spleen, and foregut. He is the editor of the widely read surgical textbook, Clinical Scenarios in Surgery: Decision Making and Operative Technique, published by Lippincott (2018). Dr. Dimick is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hernia, Obesity, Umbilical Hernia, Sleeve Gastrectomy, and Gastrectomy. Dr. Dimick is board certified in Surgery.

Dr. Mierzwa has 8 years of clinical experience in treatment of head and neck as well as gastrointestinal cancers. Her clinical research interests have included novel chemoradiation regimens for head and neck cancers as well as pancreatic cancer. Specifically, she is currently in collaboration with the Department of Otolaryngology as part of a clinical trial to identify radiographic and serum biomarkers for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation. Dr. Mierzwa is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Dry Mouth, and Pancreaticoduodenectomy. Dr. Mierzwa is board certified in Radiation Oncology.

Dr. Lagisetty serves as an Assistant Professor of Surgery in the Section of Thoracic Surgery at the University of Michigan Health System.He is a graduate from the University of Alabama at Birmingham with a degree in Philosophy in 2003 and medical degree in 2007. His General Surgical residency was completed at Beth Israel Deaconess Medical Center/Harvard Medical School. Dr. Lagisetty spent two years as a Clinical Research Fellow at the National Institutes of Health studying tumor immunology and genetic engineering/therapy. After residency he completed a two year Thoracic Surgery Fellowship at the University of Michigan.Clinical Specialization: Dr. Lagisetty specializes in all areas of general thoracic surgery, benign and malignant esophageal disorders, benign and malignant lung resections, minimally invasive including robotic techniques, lung transplantation. Dr. Lagisetty is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Congenital Diaphragmatic Hernia, Hernia, Endoscopy, and Lung Transplant. Dr. Lagisetty is board certified in Surgery and Thoracic & Cardiac Surgery.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy. Dr. Cuneo is board certified in Radiation Oncology.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Lawrence is board certified in Radiation Oncology, Medical Oncology, and Internal Medicine.

Elliot B. Tapper MD is an Associate Professor in the Division of Gastroenterology and Hepatology. He is Academic Chief of Hepatology. His primary goal is to empower patients to enjoy a high quality of life. He is an expert in the management of chronic liver disease, performance of clinical trials, and big data for the study of liver disease. He has developed strategies that reduce symptoms and improve quality of life and invented tools that have helped keep patients with cirrhosis at home and away from the hospital. He is the Editor-in-Chief of Hepatology Communications. Dr. Tapper is rated as an Experienced provider by MediFind in Pancreaticoduodenectomy. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Ascites, Liver Failure, Cirrhosis, Liver Transplant, and Pancreaticoduodenectomy. Dr. Tapper is board certified in Gastroenterology and Transplant Hepatology.